• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人低密度脂蛋白增强克隆小鼠骨髓瘤-脾杂交瘤中的极限稀释法

Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins.

作者信息

Mao S J, France D S

出版信息

J Immunol Methods. 1984 Dec 31;75(2):309-16. doi: 10.1016/0022-1759(84)90114-5.

DOI:10.1016/0022-1759(84)90114-5
PMID:6520402
Abstract

The limiting dilution technique is a critical step in the cloning of hybridomas for the preparation of monoclonal antibodies. We have found that culture medium supplemented with human plasma low density lipoproteins (LDL) markedly enhanced the yield of hybridoma clones derived from P3 X 63 Ag or FO mouse myeloma cell lines upon limiting dilution. Such enhancement was dependent on the concentration of LDL employed, being optimal at 1-10 micrograms/ml. At LDL concentrations greater than 20 micrograms/ml, the increase in yield of hybrid clones was not significant. The mechanism by which LDL enhances the yield of hybrid clones was partially elucidated by the demonstration that LDL could increase the DNA synthesis of hybridomas as assessed by [3H]thymidine incorporation. The data suggest that LDL play a role in the proliferation of hybridomas. It also indicates that LDL can be utilized for limiting dilution to increase the yield of desired clones. Since LDL is one of the most abundant lipoprotein fractions (approximately 500 micrograms/ml) in human plasma and the isolation procedure is simple, hybridoma culture medium supplemented with human LDL will prove to be a valuable reagent for investigators currently employing monoclonal antibody technology.

摘要

有限稀释技术是用于制备单克隆抗体的杂交瘤克隆过程中的关键步骤。我们发现,在有限稀释时,添加人血浆低密度脂蛋白(LDL)的培养基能显著提高源自P3 X 63 Ag或FO小鼠骨髓瘤细胞系的杂交瘤克隆产量。这种提高取决于所使用的LDL浓度,在1 - 10微克/毫升时最为理想。当LDL浓度大于20微克/毫升时,杂交克隆产量的增加并不显著。通过[3H]胸苷掺入法评估发现LDL可增加杂交瘤的DNA合成,这部分阐明了LDL提高杂交克隆产量的机制。数据表明LDL在杂交瘤增殖中发挥作用。这也表明LDL可用于有限稀释以提高所需克隆的产量。由于LDL是人类血浆中最丰富的脂蛋白组分之一(约500微克/毫升)且分离程序简单,添加人LDL的杂交瘤培养基将被证明是目前采用单克隆抗体技术的研究人员的一种有价值的试剂。

相似文献

1
Enhancement of limiting dilution in cloning mouse myeloma-spleen hybridomas by human low density lipoproteins.人低密度脂蛋白增强克隆小鼠骨髓瘤-脾杂交瘤中的极限稀释法
J Immunol Methods. 1984 Dec 31;75(2):309-16. doi: 10.1016/0022-1759(84)90114-5.
2
Serum-free medium for the growth of NS-1 mouse myeloma cells and the isolation of NS-1 hybridomas.用于NS-1小鼠骨髓瘤细胞生长及NS-1杂交瘤分离的无血清培养基。
Methods Enzymol. 1986;121:266-77. doi: 10.1016/0076-6879(86)21024-1.
3
Development of a serum-free medium for growth of NS-1 mouse myeloma cells and its application to the isolation of NS-1 hybridomas.用于NS-1小鼠骨髓瘤细胞生长的无血清培养基的开发及其在NS-1杂交瘤分离中的应用。
Anal Biochem. 1983 Apr 15;130(2):445-53. doi: 10.1016/0003-2697(83)90614-0.
4
Improved fusion technique. II. Stability and purity of hybrid clones.改良融合技术。II. 杂交克隆的稳定性和纯度。
J Immunol Methods. 1984 Mar 30;68(1-2):89-101. doi: 10.1016/0022-1759(84)90139-x.
5
Enhanced formation of mouse hybridomas without hat treatment in a serum-free medium.在无血清培养基中无需帽处理即可增强小鼠杂交瘤的形成。
In Vitro Cell Dev Biol. 1986 Jul;22(7):363-8. doi: 10.1007/BF02623523.
6
Immunochemical properties of human low density lipoproteins as explored by monoclonal antibodies. Binding characteristics distinct from those of conventional serum antibodies.
Biochim Biophys Acta. 1982 Nov 12;713(2):365-74. doi: 10.1016/0005-2760(82)90255-7.
7
Simultaneous cloning and selection of hybridomas and transfected cell lines in semisolid media.在半固体培养基中同时克隆和筛选杂交瘤细胞系及转染细胞系。
Methods Mol Biol. 2013;946:133-49. doi: 10.1007/978-1-62703-128-8_9.
8
A practical method for rescuing desired hybridomas during monoclonal antibody production.一种在单克隆抗体制备过程中挽救所需杂交瘤的实用方法。
In Vitro Cell Dev Biol. 1989 Dec;25(12):1141-6. doi: 10.1007/BF02621265.
9
Non-mitogen containing conditioned medium for hybridoma production and single cell cloning.用于杂交瘤生产和单细胞克隆的无有丝分裂原条件培养基。
Asian Pac J Allergy Immunol. 2012 Jun;30(2):114-22.
10
Serum-free medium for murine and human lymphoid and hybridoma cell lines.用于小鼠和人类淋巴细胞及杂交瘤细胞系的无血清培养基。
Cytotechnology. 1991 May;6(1):33-8. doi: 10.1007/BF00353700.

引用本文的文献

1
Establishment of a type II insulin-like growth factor receptor gene site-integrated SKBR3 cell line using CRISPR/Cas9.利用CRISPR/Cas9建立II型胰岛素样生长因子受体基因位点整合的SKBR3细胞系
Oncol Lett. 2020 Dec;20(6):354. doi: 10.3892/ol.2020.12216. Epub 2020 Oct 11.
2
A Microfluidic Single-Cell Cloning (SCC) Device for the Generation of Monoclonal Cells.一种用于生成单克隆细胞的微流控单细胞克隆 (SCC) 装置。
Cells. 2020 Jun 18;9(6):1482. doi: 10.3390/cells9061482.
3
Power analysis of statistical methods for comparing treatment differences from limiting dilution assays.
用于比较有限稀释分析中治疗差异的统计方法的功效分析。
In Vitro Cell Dev Biol. 1989 Jan;25(1):69-75. doi: 10.1007/BF02624413.